Ironwood Pharmaceuticals (IRWD) EBT Growth (3y) (2013 - 2026)
Ironwood Pharmaceuticals (IRWD) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 21.00% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 1.19% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 3.60% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -29.91% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 10.08% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 39.40% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 676.53 Mn | 597.40 Mn | - | 27.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.41% |
| Mar 31, 2026 | -0.35% |
| Dec 31, 2025 | -61.65% |
| Sep 30, 2025 | -0.91% |
| Jun 30, 2025 | -11.07% |
| Mar 31, 2025 | -38.25% |
| Dec 31, 2024 | 39.62% |
| Sep 30, 2024 | -33.73% |
| Jun 30, 2024 | -29.72% |
| Mar 31, 2024 | -50.29% |
| Dec 31, 2023 | -85.74% |
| Sep 30, 2023 | -3.75% |
| Jun 30, 2023 | -254.90% |
| Mar 31, 2023 | 170.03% |
| Dec 31, 2022 | 14.72% |
| Sep 30, 2022 | 50.16% |
| Jun 30, 2022 | 61.30% |
| Mar 31, 2022 | 61.21% |
| Dec 31, 2021 | 62.39% |
| Sep 30, 2021 | 33.59% |